InvestorsHub Logo
Followers 30
Posts 2775
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 04/30/2020 6:58:29 PM

Thursday, April 30, 2020 6:58:29 PM

Post# of 932
Upcoming (at ASCO): GEN-009, a neoantigen vaccine containing ATLAS selected neoantigens, to generate broad sustained immunity against immunogenic tumor mutations and avoid inhibitory peptides.